GENinCode Plc (AIM:GENI)
0.5000
-0.1000 (-16.67%)
Nov 20, 2026, 4:22 PM GMT
GENinCode Market Cap
GENinCode has a market cap or net worth of 3.77 million as of November 20, 2026. It is the 44,676th most valuable company in the world and the 1,008th biggest in the United Kingdom. Its market cap has decreased by 42.94% in one year.
Market Cap
3.77M
Enterprise Value
1.88M
Revenue
2.60M
Global Rank
Country Rank
#1,008 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 3.77M, a decrease of -90.75%. That is a compound annual growth rate of -36.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.14M | -39.85% |
| Dec 31, 2025 | 6.89M | 2.39% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.03B |
| GSK plc | 73.86B |
| Haleon | 30.36B |
| Smith & Nephew | 9.58B |
| OptiBiotix Health | 4.86M |
| Surgical Innovations Group | 4.68M |
| Theracryf | 4.40M |
| Cizzle Biotechnology Holdings | 4.30M |